Literature DB >> 22377764

CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.

Marta E Polak1, Louise Newell, Vadim Y Taraban, Christopher Pickard, Eugene Healy, Peter S Friedmann, Aymen Al-Shamkhani, Michael R Ardern-Jones.   

Abstract

Human cutaneous dendritic cells (DCs) from epidermal and dermal compartments exhibit functional differences in their induction of CD4+ T-cell and humoral immune responses; however, differences in the regulation of memory CD8+ T-cell responses by human skin DCs remain poorly characterized. We tested the capacity of human Langerhans cells (LCs) and dermal dendritic cells (DDCs) to induce antigen-specific cytokine production and proliferation of memory CD8+ cells. Although tumor necrosis factor-α-matured human DCs from both epidermal and dermal compartments showed efficient potential to activate CD8+ cells, LCs were constitutively more efficient than DDCs in cross-presenting CD8+ epitopes, as well as direct presentation of viral antigen to Epstein-Barr virus-specific CD8+ T cells. LCs showed greater expression of CD70, and blockade of CD70-CD27 signaling demonstrated that superiority of CD8+ activation by epidermal LC is CD70 dependent. This CD70-related activation of CD8+ cells by LCs denotes a central role of LCs in CD8+ immunity in skin, and suggests that regulation of LC CD70 expression is important in enhancing immunity against cutaneous epithelial pathogens and cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377764     DOI: 10.1038/jid.2012.26

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  28 in total

1.  Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer.

Authors:  Qinchuan Wang; Yue He; Wanlu Li; Xiaohang Xu; Qingfeng Hu; Zilong Bian; Andi Xu; Huakang Tu; Ming Wu; Xifeng Wu
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

2.  Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.

Authors:  Diane M Da Silva; Andrew W Woodham; Joseph G Skeate; Laurie K Rijkee; Julia R Taylor; Heike E Brand; Laila I Muderspach; Lynda D Roman; Annie A Yessaian; Huyen Q Pham; Koji Matsuo; Yvonne G Lin; Greg M McKee; Andres M Salazar; W Martin Kast
Journal:  Clin Immunol       Date:  2015-09-08       Impact factor: 3.969

3.  Regional differences in the density of Langerhans cells, CD8-positive T lymphocytes and CD68-positive macrophages: a preliminary study using elderly donated cadavers.

Authors:  Yuya Omine; Nobuyuki Hinata; Masahito Yamamoto; Masaaki Kasahara; Satoru Matsunaga; Gen Murakami; Shin-Ichi Abe
Journal:  Anat Cell Biol       Date:  2015-09-22

4.  ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.

Authors:  Karen Silence; Torsten Dreier; Mahan Moshir; Peter Ulrichts; Sofie M E Gabriels; Michael Saunders; Harald Wajant; Peter Brouckaert; Leander Huyghe; Tim Van Hauwermeiren; Alain Thibault; Hans J De Haard
Journal:  MAbs       Date:  2013-12-06       Impact factor: 5.857

5.  Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells.

Authors:  Cynthia M Fehres; Sanne Duinkerken; Sven Cm Bruijns; Hakan Kalay; Sandra J van Vliet; Martino Ambrosini; Tanja D de Gruijl; Wendy Wj Unger; Juan J Garcia-Vallejo; Yvette van Kooyk
Journal:  Cell Mol Immunol       Date:  2015-10-12       Impact factor: 11.530

6.  Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.

Authors:  Andreas Lundqvist; Aleah L Smith; Yoshiyuki Takahashi; Susan Wong; Erkut Bahceci; Lisa Cook; Catalina Ramos; Abdul Tawab; J Philip McCoy; Elizabeth J Read; Hanh M Khuu; Charles D Bolan; Jungnam Joo; Nancy Geller; Susan F Leitman; Gary Calandra; Cynthia Dunbar; Roger Kurlander; Richard W Childs
Journal:  J Immunol       Date:  2013-11-15       Impact factor: 5.422

7.  Distinct molecular signature of human skin Langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation.

Authors:  Marta E Polak; Stephen M Thirdborough; Chuin Y Ung; Tim Elliott; Eugene Healy; Tom C Freeman; Michael R Ardern-Jones
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

Review 8.  Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets.

Authors:  Enric Gutiérrez-Martínez; Remi Planès; Giorgio Anselmi; Matthew Reynolds; Shinelle Menezes; Aimé Cézaire Adiko; Loredana Saveanu; Pierre Guermonprez
Journal:  Front Immunol       Date:  2015-07-17       Impact factor: 7.561

9.  Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7.

Authors:  Stephanie van de Wall; Mateusz Walczak; Nienke van Rooij; Baukje-Nynke Hoogeboom; Tjarko Meijerhof; Hans W Nijman; Toos Daemen
Journal:  Vaccines (Basel)       Date:  2015-03-24

10.  Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells.

Authors:  Maxim N Artyomov; Adiel Munk; Laurent Gorvel; Daniel Korenfeld; Marina Cella; Thomas Tung; Eynav Klechevsky
Journal:  J Exp Med       Date:  2015-04-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.